Pemovska, Tea
Austrian Academy of Sciences · CeMM Research Center for Molecular Medicine · Medical University of Vienna
6 papers on CoChatORCID 0000-0003-2951-4905
Most cited papers
- Verified
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
Pemovska, T., Johnson, E., Kontro, M., Repasky, G. A., Chen, J., Wells, P., Cronin, C. N., McTigue, M., Kallioniemi, O., Porkka, K., et al. (2015) · Nature
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 234
- Verified
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Kornauth, C., Pemovska, T., Vladimer, G. I., Bayer, G., Bergmann, M., Eder, S., Eichner, R., Erl, M., Esterbauer, H., Exner, R., et al. (2022) · Cancer Discovery
Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research
Cited by 206
- Verified
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
Schmidl, C., Vladimer, G. I., Rendeiro, A. F., Schnabl, S., Krausgruber, T., Taubert, C., Krall, N., Pemovska, T., Araghi, M., Snijder, B., et al. (2019) · Nature Chemical Biology
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 39
- Verified
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine
Heinemann, T., Kornauth, C., Severin, Y., Vladimer, G. I., Pemovska, T., Hadzijusufovic, E., Agis, H., Krauth, M.-T., Sperr, W. R., Valent, P., et al. (2022) · Blood Cancer Discovery
Digital Imaging for Blood DiseasesAcute Myeloid Leukemia Research
Cited by 28
- Verified
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
Pietarinen, P. O., Pemovska, T., Kontro, M., Yadav, B., Mpindi, J. P., Andersson, E. I., Majumder, M. M., Kuusanmäki, H., Koskenvesa, P., Kallioniemi, O., et al. (2015) · Blood Cancer Journal
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 25
- Verified
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
Pietarinen, P. O., Eide, C. A., Ayuda-Durán, P., Potdar, S., Kuusanmäki, H., Andersson, E. I., Mpindi, J. P., Pemovska, T., Kontro, M., Heckman, C. A., et al. (2017) · Oncotarget
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free